#ecopipam

Ecopipam reduces stuttering symptoms in proof-of-concept trial — ScienceDaily

A team led by a psychiatrist at the University of California, Riverside, has tested the orally administered investigational medication ecopipam on adults who stutter in an open-label, uncontrolled clinical trial and found that it reduced their stuttering symptoms from the start of therapy after eight weeks of dosing.

Positive results included increased speech fluency, faster reading completion,…